![Michael Hufford](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Hufford
Director Ejecutivo en LyGenesis, Inc. .
Perfil
Michael Hufford was the founder of e-Nicotine Technology, Inc. where he held the title of Chief Medical Officer & Director.
He is also the founder of LyGenesis, Inc. Dr. Hufford's current job is as a Director at Morphoceuticals, Inc.
Cargos activos de Michael Hufford
Empresas | Cargo | Inicio |
---|---|---|
LyGenesis, Inc.
![]() LyGenesis, Inc. BiotechnologyHealth Technology LyGenesis, Inc. operates as a biotechnology company. It develops an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to regrow functioning ectopic organs. The company is headquartered in Pittsburgh, PA. | Director Ejecutivo | 01/05/2018 |
Morphoceuticals, Inc.
![]() Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Morphoceuticals, Inc. is an American US-based biotech company that pioneers bioelectric approaches to access anatomical programming, which is a core component of our biological operating system. The company uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and treat channelopathies. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Michael Hufford.
Empresas | Cargo | Fin |
---|---|---|
e-Nicotine Technology, Inc.
![]() e-Nicotine Technology, Inc. BiotechnologyHealth Technology e-Nicotine Technology, Inc. develops next generation of state-of-the-art electronic nicotine delivery products. It engages in developing electronic nicotine delivery devices that produce a condensation aerosol of nicotine using its thermal drug delivery technology. The firm’s devices deliver the right dose of nicotine using the right sized aerosol particles for deep lung delivery to help individuals transition from smoking. The company was founded by Jeffrey S. Williams, Michael Hufford and Martin Wensley in 2012 and is headquartered in Draper, UT. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
e-Nicotine Technology, Inc.
![]() e-Nicotine Technology, Inc. BiotechnologyHealth Technology e-Nicotine Technology, Inc. develops next generation of state-of-the-art electronic nicotine delivery products. It engages in developing electronic nicotine delivery devices that produce a condensation aerosol of nicotine using its thermal drug delivery technology. The firm’s devices deliver the right dose of nicotine using the right sized aerosol particles for deep lung delivery to help individuals transition from smoking. The company was founded by Jeffrey S. Williams, Michael Hufford and Martin Wensley in 2012 and is headquartered in Draper, UT. | Health Technology |
LyGenesis, Inc.
![]() LyGenesis, Inc. BiotechnologyHealth Technology LyGenesis, Inc. operates as a biotechnology company. It develops an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to regrow functioning ectopic organs. The company is headquartered in Pittsburgh, PA. | Health Technology |
Morphoceuticals, Inc.
![]() Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Morphoceuticals, Inc. is an American US-based biotech company that pioneers bioelectric approaches to access anatomical programming, which is a core component of our biological operating system. The company uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and treat channelopathies. | Commercial Services |
- Bolsa de valores
- Insiders
- Michael Hufford